For years, Lynn Milam's life was consumed by the debilitating pain of rheumatoid arthritis. Simple acts like hugging her children or holding her husband's hand became impossible. The relentless inflammation left her confined to the couch, unable to participate in daily life. Despite trying numerous treatments – physical therapy, acupuncture, steroids, and even the latest immune-modulating drugs – nothing provided lasting relief. Then, in October 2023, everything changed.
A groundbreaking experimental device offered a lifeline. A tiny nerve stimulator, implanted in her neck, delivers targeted electrical pulses to the vagus nerve. This nerve, connecting the brain to internal organs, plays a crucial role in regulating the body's inflammatory response. Within weeks, Milam experienced remarkable results. The excruciating elbow and hand pain vanished, swelling subsided, and the crippling symptoms of rheumatoid arthritis disappeared.
"It's like a rebirth," she shares, describing the transformative impact on her life and her relationship with her husband. The approval of this innovative device by the Food and Drug Administration (FDA) in July 2025 marks a significant advancement in the treatment of severe rheumatoid arthritis. Developed by SetPoint Medical, the device is now available to patients whose symptoms haven't responded to conventional drug therapies.
The device's mechanism of action centers on its interaction with the vagus nerve and the hypothalamus, a brain region that influences the immune system. By stimulating the vagus nerve, the device modulates the production of cytokines – proteins that regulate inflammation. While cytokines are crucial for fighting infection, their overproduction can damage healthy tissues, as seen in rheumatoid arthritis. The stimulator helps to reduce this overproduction, thereby easing the inflammation.
While not every patient experiences the dramatic recovery that Milam did, the clinical trials showed significant improvement in a substantial portion of patients who had failed to respond to other treatments. Dr. John Tesser, a rheumatologist involved in the pivotal study, highlighted that 35% of participants in this difficult-to-treat group achieved meaningful symptom relief, a significant improvement over the control group.
The procedure itself is minimally invasive, akin to a straightforward outpatient surgery. Dr. Peter Konrad, chair of neurosurgery at the Rockefeller Neuroscience Institute, describes the implant as "the size of a lima bean." Milam herself notes that the surgery was less complicated than some dental procedures she'd had. Though a minor complication briefly affected her voice, it was quickly resolved, leaving only a slightly lowered tone – a small price to pay for the restored quality of life.
This FDA approval isn't just a victory for those with rheumatoid arthritis. It holds significant promise for other autoimmune diseases, including multiple sclerosis and inflammatory bowel disease, offering a potential new pathway towards managing chronic inflammation and regaining lost functionality. The ability to hold hands, walk the dog, and simply embrace loved ones – these simple joys, once unattainable for Lynn Milam, are now a reality thanks to this revolutionary medical breakthrough.
---
Originally published at: https://www.npr.org/sections/shots-health-news/2025/09/22/nx-s1-5544463/rheumatoid-arthritis-new-device-nerve-stimulator
